Investment Research of China Medical Device Industry under the Concept of Corporate Finance — Take Yuyue Medical Co., Ltd. as Example

Authors

  • Junyao Hu

DOI:

https://doi.org/10.61173/46a1hs43

Keywords:

Yuyue Medical Co, Ltd, Chinese Medical Device Industry, Porter’s Five Forces Analysis, Corporate Finance

Abstract

With the optimization of China’s healthcare policy, the rise of the aging population, the increasing health awareness of society, and the impact of the global epidemic, China’s medical device industry has become a key market for investors. However, compared with the mature and well-funded medical device companies in overseas developed countries, China’s local medical device companies have apparent disadvantages and jumping battles. Yuyue Medical Co., Ltd. is a prominent player in the medical device industry in China, having sustained a significant profit margin over an extended period. Its profitability has changed over the post-epidemic period, in any case. Given Yuyue Medical Co., Ltd.’s exceptional standing in the medical equipment sector, an analysis of the company as an industry investment case makes sense. Based on Yuyue Medical Co., Ltd. as the industry investment benchmark, the study analyses the industry’s competitive development situation, financial performance, and impact on the external environment by adopting Porter’s Five Forces, ratio analysis, and PESTEL. The study found that China’s medical device industry has growth potential due to the low bargaining power of customers and suppliers, high technological barriers, and low threat of substitution by new entrants. Yuyue Medical Co., Ltd. has healthy financial performance and several advantages from the external environment, so Yuyue Medical Co., Ltd. is worthy of investment.

References

[1] Roland Berger. China Medical Device Industry Development Status and Trends Report. Febuary, 2023. Retrieved on Auguest 22, 2024.

[2] Li, WX. Research on the profitability of Yuyue Medical based on improved DuPont analysis system. Shihezi University, 2023.DOI:10.27332/d.cnki.gshzu.2023.000489.

[3] Li, Q., Li, YX. Competitive Strategy Analysis of State-owned Enterprise Hospital Based on Porter’s Five Forces Model. Hebei Dean&Francis Qiye, 2024, (05):73-75.

[4] Cheng, MT. A comparative Study of Financial Ratios in the Hotel Industry Before and After the Epidemic. China Market, 2024, 18:142-145.

[5] Liang, PB., Guo, K. SWOT-PESTEL Model Analysis of Dairy Industry in Ningxia under the Background of High-quality Development [J]. China Dairy, 2024, (01):2-8.

[6] Lv, QL., Ye, XY. Research on the development status quo and development countermeasures of household medical equipment industry in 2021.Chinese Journal of Medical Instrumentation, 2022, (28):12-14+116.

[7] Tian SW. Research on the synergistic effect of merger and acquisition integration of listed companies of medical devices in China--Taking Yuyue Medical as an example[J]. Contemporary Economics, 2020, (05):38-40.

[8] Chu ZF, Jumuddin F. Based on the perspective of the healthcare industry, a study on the medical device market’s significant growth and contribution to the Chinese economy[J]. International Journal of Social Science and Human Research (IJSSHR), 2024, 7(01): 69-76.

[9] Zhang W, Chatwin C. Trade competitiveness analysis of the Chinese medical device industry[J]. International Journal of Trade and Global Markets, 2023, 17(1): 64-87.

[10] Li P, Li YH. Analysis of the health status of the elderly in China and research on countermeasures[J]. Life & Lovers,2024, (09):76-78.

[11] Yuyue Medical Co., Ltd. Yuyue Medical Co., Ltd. Invited to Attend China Medical Artificial Intelligence Conference, Sharing Experience of AI Enabling Home Medical Devices. December 11, 2022. Retrieved on August 22, 2024. Retrieved from: https:// www.yuwell.com/index.php/news/newsinfo/124.html

[12] PR Newswire. Yuyue Medical Co., Ltd. disclosed its first sustainable development report: governance integration, innovation, solid foundation, and green co-construction. April 27, 2023. Retrieved on August 22, 2024. Retrieved from: https:// www.prnasia.com/story/445037-1.shtml

[13] State Administration for Market Regulation. The General Administration of Market Regulation issued the “supervision and management measures for the production of medical devices” AND “supervision and management measures for the operation of medical devices” shall come into force on May 1, 2022. March 22, 2022. Retrieved on August 22, 2024. Retrieved from: https://www.samr.gov.cn/xw/zj/art/2023/art_46a4f3d9ba7 34f1384d63cbd9e668262.html

Downloads

Published

2024-10-29